Cargando…
Sparse whole genome sequencing identifies two loci for major depressive disorder
Major depressive disorder (MDD), one of the most frequently encountered forms of mental illness and a leading cause of disability worldwide(1), poses a major challenge to genetic analysis. To date no robustly replicated genetic loci have been identified (2), despite analysis of more than 9,000 cases...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522619/ https://www.ncbi.nlm.nih.gov/pubmed/26176920 http://dx.doi.org/10.1038/nature14659 |
Ejemplares similares
-
Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder
por: Xu, Zhi, et al.
Publicado: (2020) -
Whole Genome Sequencing Revealed Inherited Rare Oligogenic Variants Contributing to Schizophrenia and Major Depressive Disorder in Two Families
por: Chung, I-Hang, et al.
Publicado: (2023) -
High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder
por: Tombácz, Dóra, et al.
Publicado: (2017) -
Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia
por: Ward, Joey, et al.
Publicado: (2017) -
Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models
por: Yu, Sung-Liang, et al.
Publicado: (2021)